Solborn Past Earnings Performance

Past criteria checks 3/6

Solborn has been growing earnings at an average annual rate of 16.8%, while the Medical Equipment industry saw earnings growing at 19.3% annually. Revenues have been growing at an average rate of 9.2% per year. Solborn's return on equity is 20.3%, and it has net margins of 29.2%.

Key information

16.8%

Earnings growth rate

17.1%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate9.2%
Return on equity20.3%
Net Margin29.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Solborn (KOSDAQ:035610) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Nov 20
Solborn (KOSDAQ:035610) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Why Solborn's (KOSDAQ:035610) Earnings Are Weaker Than They Seem

Mar 30
Why Solborn's (KOSDAQ:035610) Earnings Are Weaker Than They Seem

Recent updates

Solborn (KOSDAQ:035610) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Nov 20
Solborn (KOSDAQ:035610) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Why Solborn's (KOSDAQ:035610) Earnings Are Weaker Than They Seem

Mar 30
Why Solborn's (KOSDAQ:035610) Earnings Are Weaker Than They Seem

Solborn's (KOSDAQ:035610) Returns On Capital Are Heading Higher

May 03
Solborn's (KOSDAQ:035610) Returns On Capital Are Heading Higher

Is Solborn (KOSDAQ:035610) A Risky Investment?

Mar 01
Is Solborn (KOSDAQ:035610) A Risky Investment?

What Kind Of Investors Own Most Of Solborn, Inc. (KOSDAQ:035610)?

Feb 03
What Kind Of Investors Own Most Of Solborn, Inc. (KOSDAQ:035610)?

Investors Who Bought Solborn (KOSDAQ:035610) Shares A Year Ago Are Now Up 48%

Jan 03
Investors Who Bought Solborn (KOSDAQ:035610) Shares A Year Ago Are Now Up 48%

Calculating The Intrinsic Value Of Solborn, Inc. (KOSDAQ:035610)

Dec 08
Calculating The Intrinsic Value Of Solborn, Inc. (KOSDAQ:035610)

Revenue & Expenses Breakdown

How Solborn makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A035610 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24128,22137,44342,7788,976
30 Jun 24129,19037,14042,8979,054
31 Mar 24125,80539,05842,3478,720
31 Dec 23123,38338,24939,8298,635
30 Sep 23114,241-4,00439,5918,615
30 Jun 23105,594-6,59738,7798,357
31 Mar 2398,180-29,55239,4578,175
31 Dec 2293,816-41,71238,8248,039
30 Sep 2287,574-18,72634,6577,812
30 Jun 2287,950-16,46434,8497,627
31 Mar 2285,036-5,13432,5277,704
31 Dec 21100,19917,82231,3247,378
30 Sep 2199,66222,82932,8626,812
30 Jun 21101,36820,36631,2986,303
31 Mar 21109,07629,08729,5695,942
31 Dec 2082,0391,44830,0635,757
30 Sep 2082,139-5,32032,6586,598
30 Jun 2077,998-4,35531,8736,786
31 Mar 2072,542-7,59633,7346,864
31 Dec 1980,3121,78032,8916,806
30 Sep 1992,36117,39232,6206,401
30 Jun 1990,09616,75232,3936,472
31 Mar 1985,63910,58032,1546,747
31 Dec 1884,44110,19831,0186,782
30 Sep 1863,837-4,05727,9396,561
30 Jun 1866,493-2,91630,5345,007
31 Mar 1868,701-3,21829,7094,722
31 Dec 1774,109-3,30529,1245,146
30 Sep 1770,6142,75021,4594,771
30 Jun 1771,40671123,0384,771
31 Mar 1775,1384,26026,7964,459
31 Dec 1674,4893,42128,1044,322
30 Sep 1676,040-4,57237,4523,617
30 Jun 1674,165-2,23336,7583,617
31 Mar 1668,568-4,94034,5633,180
31 Dec 1570,4971,48733,2903,048
30 Sep 1571,1289,53430,1883,397
30 Jun 1570,00213,99329,3363,397
31 Mar 1573,90012,45732,8783,239
31 Dec 1471,6376,63332,9815,144
30 Sep 1474,6804,12734,8795,721
30 Jun 1485,983-1,92236,8725,721
31 Mar 1490,4432,60437,6916,983
31 Dec 1393,8364,01239,3576,647

Quality Earnings: A035610 has a large one-off gain of ₩20.0B impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: A035610 became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A035610's earnings have grown by 16.8% per year over the past 5 years.

Accelerating Growth: A035610 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: A035610 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-16.5%).


Return on Equity

High ROE: A035610's Return on Equity (20.3%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 14:30
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Solborn, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution